Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years

Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years ORIGINAL ARTICLE Diagnostic Performance of Low-Dose Computed  Tomography Screening for Lung Cancer over Five Years Giulia Veronesi, MD,* Patrick Maisonneuve, DipEng,† Lorenzo Spaggiari, MD,*‡ Cristiano Rampinelli, MD,§ Alessandro Pardolesi, MD,* Raffaella Bertolotti, MSc,* Niccolò Filippi, MD,* and Massimo Bellomi, MD‡§ advanced cancers, and misdiagnoses, need to be reduced, perhaps by Introduction: Low-dose computed tomography (LD-CT) screen- risk modeling and use of serum markers. ing can reduce lung cancer mortality; however, it is essential to improve nodule management protocols. We analyze the perfor- Key Words: Lung cancer, Computed tomography, Screening, mance of the diagnostic protocol of the Continuous Observation of Surgery. SMOking Subjects single-center screening study, after long-term (J Thorac Oncol. 2014;9: 935–939) follow-up. Methods: Between 2004 and 2005, 5203 asymptomatic high-risk individuals (≥20 pack-years, aged 50 years or older) were enrolled arly detection is essential for successful lung cancer to undergo annual LD-CT for 5 years. Nodules 5 mm or smaller Etreatment. During the last 15 years, several studies underwent repeat LD-CT a year later. Nodules larger than 5.0 mm have shown that low-dose computed tomography (LD-CT), and 8.0 mm or smaller received LD-CT 3 to 6 months later. Nodules without contrast, can reliably diagnose lung nodules of a larger than 8.0 mm or growing underwent CT-positron emission few millimeters http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years

Journal of Thoracic Oncology , Volume 9 (7) – Jul 1, 2014

Loading next page...
 
/lp/wolters-kluwer-health/diagnostic-performance-of-low-dose-computed-tomography-screening-for-Wk0TxZUPmj

References (30)

Copyright
Copyright © 2014 by the International Association for the Study of Lung Cancer
ISSN
1556-0864
DOI
10.1097/JTO.0000000000000200
pmid
24922008
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Diagnostic Performance of Low-Dose Computed  Tomography Screening for Lung Cancer over Five Years Giulia Veronesi, MD,* Patrick Maisonneuve, DipEng,† Lorenzo Spaggiari, MD,*‡ Cristiano Rampinelli, MD,§ Alessandro Pardolesi, MD,* Raffaella Bertolotti, MSc,* Niccolò Filippi, MD,* and Massimo Bellomi, MD‡§ advanced cancers, and misdiagnoses, need to be reduced, perhaps by Introduction: Low-dose computed tomography (LD-CT) screen- risk modeling and use of serum markers. ing can reduce lung cancer mortality; however, it is essential to improve nodule management protocols. We analyze the perfor- Key Words: Lung cancer, Computed tomography, Screening, mance of the diagnostic protocol of the Continuous Observation of Surgery. SMOking Subjects single-center screening study, after long-term (J Thorac Oncol. 2014;9: 935–939) follow-up. Methods: Between 2004 and 2005, 5203 asymptomatic high-risk individuals (≥20 pack-years, aged 50 years or older) were enrolled arly detection is essential for successful lung cancer to undergo annual LD-CT for 5 years. Nodules 5 mm or smaller Etreatment. During the last 15 years, several studies underwent repeat LD-CT a year later. Nodules larger than 5.0 mm have shown that low-dose computed tomography (LD-CT), and 8.0 mm or smaller received LD-CT 3 to 6 months later. Nodules without contrast, can reliably diagnose lung nodules of a larger than 8.0 mm or growing underwent CT-positron emission few millimeters

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Jul 1, 2014

There are no references for this article.